Altered growth pattern, not altered growth per se, is the hallmark of early lesions preceding cancer development

Histology and Histopathology

Volumn 24, Issue 1, 2009, Pages 101-106

  Doratiotto, Silvia ^a   Marongiu, Fabio ^a   Faedda, Simona ^a   Pani, Paolo ^a   Laconi, Ezio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Clonal growth; Focal growth; Focal lesions; Growth pattern; Tumor microenvironment

Indexed keywords

CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CLONE; CELL TRANSFORMATION; COLON CANCER; COLON CARCINOGENESIS; DISEASE ACTIVITY; DISEASE COURSE; GENETIC RISK; GROWTH REGULATION; HISTOPATHOLOGY; LIVER CANCER; LIVER CARCINOGENESIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOLECULAR CLONING; NONHUMAN; PATHOLOGICAL ANATOMY; PHENOTYPE; PRECANCER; REVIEW; TISSUE STRUCTURE; ANIMAL; CELL PROLIFERATION; HUMAN; MORPHOGENESIS; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BODY PATTERNING; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS;

EID: 60549106525     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Anderson A.R.A., Weiver A.M., Cummings P.T. and Quaranta V. (2006). Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127, 905-915.
2. Barrett J.C., Kakunaga T., Kuroki T., Neubert D., Trosko J.E., Vasiliev J.M., Williams G.M. and Yamasaki H. (1986). Short-term assays to predict carcinogenicity. In-vitro assays that may be predictive of tumour-promoting agents. IARC Sci. Publ. 83, 287-302.
3. Berman J., Albores-Saavedra J., Bostwick D., DeLellis R., Eble J., Hamilton S.R., Hruban R.H., Mutter G.L., Page D., Rohan T., Travis W. and Henson D.E. (2006). Precancer: A conceptual working definition - Results of a Consensus Conference. Cancer Detect. Prev. 30, 387-394.
4. Bindra R.S. and Glazer P.M. (2005). Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat. Res. 569, 75-8.
5. Buscarlet M. and Stifani S. (2007). The 'Marx' of Groucho on development and disease. Trends Cell. Biol. 17, 353-361.
6. Cairns J. (2006). Cancer and the immortal strand hypothesis. Genetics 174, 1069-72.
7. Capp J-P. (2005). Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development. BioEssays 27, 1277-85.
8. Christofori G. (2006). New signals from the invasive front. Nature 441, 444-450.
9. Clark W.R. Jr., Elder D.E., Guerry D. 4th, Epstein M.N., Greene M.H. and Van Horn M. (1984). A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol. 15, 1147-1165.
10. Corson T.W. and Gallie B.L. (2007). One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer 46, 617-34.
11. Costa A. (2006). Precancerous lesions of the breast. Ann. Oncol. 17, x271-x273.
12. Dalmay T. and Edwards, D.R. (2006). MicroRNAs and the hallmarks of cancer. Oncogene 25, 6170-75.
13. De Vree J.M.L., Ottenhoff R., Bosma P.J., Smith A.J., Aten J., R.P.J. and Oude-Elferink (2000). Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119, 1720-1730.
14. Diallo R., Schaefer K.L., Poremba C., Shivazi N., Willmann V., Buerger H., Dockhorn-Dworniczak B. and Boecker W. (2001). Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J. Pathol. 193, 27-32.
15. Drachenberg C.B. and Papadimitriou J.C. (1995). Aberrant pattern of lectin binding in low and high grade prostatic intraepithelial neoplasia. Cancer 75, 2539-44.
16. Ellegren H. (2007). Characteristics, causes and evolutionary consequences of male-biased mutation. Proc. Biol. Sci. 274, 1-10.
17. Fearon E.R. and Vogelstein B. (1990). A genetic model for colorectal tumorigenesis. Cell 61, 759-767.
18. Fischer A.H., Young K.A. and DeLellis R.A. (2004). Incorporating pathologists' criteria of malignancy into the evolutionary model for cancer development. J. Cell. Biochem. 93, 28-36.
19. Foulds L. (1975). Neoplastic development. Vol 2. Academic Press. pp 1-15.
20. Garcia S.B., Novelli M. and Wright N.A. (2000). The clonal origin and clonal evolution of epithelial tumours. Int. J. Exp. Pathol. 81, 89-116.
21. Gatenby R.A., Gawlinski E.T., Gmitro A.F., Kaylor B. and Gillies R.J. (2006). Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66, 5216-5223.
22. Gottlieb B., Beitel L.K. and Trifiro M. (2007). Will knowledge of human genome variation result in changing cancer paradigms? BioEssays 29, 678-685.
23. Hagendoorn J., Tong R., Fukumura D., Lin Q., Lobo J., Padera T.P., Xu L., Kucherlapati R. and Jain R.K. (2006). Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res. 66, 3360-64.
24. Hanahan D. and Weinberg R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
25. Hruban R.H., Wilentz R.E. and Maitra A. (2005). Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol. Med. 103, 1-13.
26. Iannacone P.M., Weinberg W.C. and Deamant F.D. (1987). On the clonal origin of tumors: a review of experimental models. Int. J. Cancer 39, 778-784.
27. Ingber D.E. (2002). Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Differentiation 70, 547-60.
28. Knudson A.G. Jr (1971). Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820-823.
29. Kren B.T., Kumar N.M., Wang S.Q., Gilula N.B. andSteer C.J. (1993). Differential regulation of multiple gap junction transcripts and proteins during rat liver regeneration. J. Cell Biol. 123, 707-18.
30. Krutovskikh V.A., Oyamada M. and Yamasaki H. (1991). Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: direct measurement of communication in vivo. Carcinogenesis 12, 1701-1706.
31. Laconi E. (2007). The evolving concept of tumor microenvironments. BioEssays 29, 1-7.
32. Laconi S., Pillai S., Porcu P.P., Shafritz D.A., Pani P. and Laconi E. (2001a) Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am. J. Pathol. 158, 771-777.
33. Laconi S., Pani P., Pillai S., Pasciu D., Sarma D.S.R. and Laconi E. (2001b). A growth constrained environment drives tumor progression in vivo. Proc. Natl. Acad. Sci. USA 98, 7806-7811.
34. Laconi S., Curreli F., Diana S., Pasciu D., De Filippo G., Sarma D.S.R., Pani P. and Laconi E. (1999). Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study. J. Hepatol. 31, 1069-1074.
35. Laconi E., Oren R., Mukhopadhyay D.K., Hurston E., Laconi S., Pani P., Dabeva M. and Shafritz D. (1998). Long term, near total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am. J. Pathol. 158, 319-329.
36. Li C.Y., Little J.B., Hu K., Zhang W., Zhang L., Dewhirst M.W. and Huang Q. (2001). Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures. Cancer Res. 61, 428-432.
37. Libbrecht L., Desmet V. and Roskams T. (2005). Preneoplastic lesions in human hepatocarcinogenesis. Liver Int. 25, 16-27.
38. Loch-Caruso R. and Trosko J.E. (1985). Inhibited intercellular communication as a mechanistic link between teratogenesis and carcinogenesis. Crit. Rev. Toxicol. 16, 157-83.
39. Luebeck E.F., Buchmann A., Stinchcombe S., Moolgavkar S.H. and Schwarz M. (2000). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: A quantitative analysis of experimental data using a stochastic model. Toxicol. Appl. Pharmacol. 167, 63-73.
40. Macaluso M., Paggi M.G. and Giordano A. (2003). Genetic and epigenetic alterations as hallmarks of the intricate road to cancer. Oncogene 22, 6472-6478.
41. Malumbres M. and Barbacid M. (2001). To cycle or not to cycle: a critical decision in cancer. Nat. Rev. Cancer 1, 222-231.
42. Marongiu F., Doratiotto S., Montisci S., Pani P. and Laconi E. (2008). Liver repopulation and carcinogenesis: two sides of the same coin? Am. J. Pathol. 172, 857-864.
43. Mikels A.J. and Nusse R. (2006). Wnts as ligands: processing, secretion and reception. Oncogene 25, 7461-8.
44. Neveu M.J., Hully J.R., Babcock K.L., Hertzberg E.L., Nicholson B.J., Paul D.L. and Pitot H.C. (1994). Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver. J. Cell Sci. 107, 83-95.
45. Niho S., Yokose T., Suzuki K., Kodama Y. and Mukai K. (1999). Monoclonality of atypical adenomatous hyperplasia of the lung. Am. J. Pathol. 154, 249-254.
46. Noguchi S., Motomura K., Inaji H., Imoaka S. and Koyama H. (1992). Clonal analysis of human breast cancer by means of the polymerase chain reaction. Cancer Res. 52, 6594-6597.
47. Oliveira P.A., Colaço A., De la Cruz L.F., Lopes P. and Lopes C. (2006). E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats. Exp. Clin. Cancer Res. 25, 425-432.
48. Overturf K., Al-Dhalimy M., Tanguay R., Brantly M., Ou C-N., Finegold M. and Grompe M. (1996). Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tryosinaemia type I. Nature Genet. 12, 266-273.
49. Park Y.N., Yang C.P., Cubukcu O., Thung S.N. and Theise N.D. (1997). Hepatic stellate cell activation in dysplastic nodules: evidence for an alternate hypothesis concerning human hepatocarcinogenesis. Liver 17, 271-274.
50. Park Y. and Roncalli M. (2006). Large liver cell dysplasia: A controversial entity. J. Hepatol. 45, 734-743.
51. Polyac K. and Hahn W.C. (2006). Roots and stems: stem cells in cancer. Nat. Med. 12, 296-300.
52. Potter V.R. (1980). Initiation and promotion in cancer formation: the importance of studies on intercellular communication. Yale J. Biol. Med. 53, 367-384.
53. Pugacheva E.N., Roegiers F. and Golemis E.A. (2006). Interdependence of cell attachment and cell cycle signaling. Curr. Opin. Cell Biol. 18, 507-5115.
54. Rando T.A. (2007). The immortal strand hypothesis: segregation and reconstruction. Cell 129, 1239-1243.
55. Rhim J.A., Sandgren E.P., Degen J.L., Palmiter R.D. and Brinster R.L. (1994). Replacement of diseased mouse liver by hepatic cell transplantation. Science 263, 1149-1152.
56. Robinson W.A., Lemon M., Elefanty A., Harrison-Smith M., Markham N. and Norris D. (1998). Human acquired naevi are clonal. Melanoma Res. 8, 499-503.
57. Russell R.C. and Ohh M. (2007). The role of VHL in the regulation of E-cadherin: a new connection in an old pathway. Cell Cycle 6, 56-59.
58. Schwartz M.A. and Ingber D. (1994). Integrating with integrins. Mol. Biol. Cell 5, 389-393.
59. Semenza G.L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
60. Shpitz B., Bomstein Y., Mecori Y., Cohen R., Kaufman Z., Neufeld D., Galkin M. and Bernheim J. (1998). Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum. Pathol. 29, 469-475.
61. Smits R., Ruiz P., Diaz-Cano S., LuZ A., Jagmohan-Changur S., Breukel C., Birchmeier C., Birchmeier W. and Fodde R. (2000). E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice. Gastroenterology 119, 1045-1053.
62. Solt D.B., Hay J.B. and Farber E. (1997). Comparison of the blood supply to diethylnitrosamine-induced hyperplastic nodules and hepatomas and to the surrounding liver. Cancer Res. 37, 1689-1691.
63. Valizadeh A., Karayiannakis A.J., el-Hariry I., Kmiot W. and Pignatelli M. (1997). Expression of E-cadherin-associated molecules (alpha-,beta-, and gamma-catenins and p120) in colorectal polyps. Am. J. Pathol. 150, 1977-1984.
64. Walsh D.S., Tsou H.C., Harrington A., James W.D. and Peacocke M. (1996). Clonality of basal cell carcinoma - molecular analysis of an interesting case. J. Invest. Dermatol. 106, 579-582.
65. Weinberg W.C. and Iannacone P.M. (1988). Clonality of preneoplastic liver lesions: histological analysis in chimeric rats. J. Cell Sci. 89, 423-431.
66. Xu R-h., Pelicano H., Zhou Y., Carew J.S., Feng L., Bhalla K.N., Keating M.J. and Huang P. (2005). Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 65, 613-621.
67. Yamasaki H., Enomoto T. and Martel N. (1984) Intercellular communication, cell differentiation and tumour promotion. IARC Sci. Publ. 56, 217-238.
68. Zhong H., Semenza G.L., Simons J.W. and De Marzo A.M. (2004). Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect. Prev. 28, 88-93.